Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China-Reference-Cited by-同舟云学术

Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China

Published:2018-04-10 Issue:4 Volume:13 Page:e0195117
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lu Yun,Jin Xiuze,Duan Cheng-a-xin,Chang Feng^ORCID

Funder

National Natural Science Foundation of China

Postgraduate Research & Practice Innovation Program of Jiangsu Province

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes;A Petruzziello;World Journal of Gastroenterology,2016

2. Hepatitis C virus infections and genotypes in China;YD Chen;Hepatobiliary & pancreatic diseases international: HBPD INT,2002

3. Hepatitis C virus infection in China: an emerging public health issue;Q Qin;Journal of Viral Hepatitis,2015

4. Global epidemiology and genotype distribution of the hepatitis C virus infection;E Gower;Journal of hepatology,2014

5. Cancer today. Estimated age-standardized rates (World) of incident cases, both sexes, liver cancer, Asia in 2012. http://gco.iarc.fr/today/online-analysis-map. Accessed December 2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China;Frontiers in Public Health;2021-12-09

2. Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection;Annals of Palliative Medicine;2021-10

3. Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China;PLOS ONE;2021-01-13

4. Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C;Applied Health Economics and Health Policy;2020-11-19

A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants

;Clinical Pharmacology: Advances and Applications;2020-02